The pill featuring the imprint T 259 is a combination prescription medication composed of Hydrocodone Bitartrate and Acetaminophen. It is a potent analgesic (pain reliever) prescribed primarily for the management of moderate to severe acute pain when alternative non-opioid treatments are inadequate.
Because it contains an opioid, this medication is classified as a Schedule II Controlled Substance in the United States, meaning it has a high potential for abuse, dependence, and addiction.
Pill Identification
- Imprint: T 259
- Color: White (occasionally yellow depending on the specific generic manufacturer)
- Shape: Capsule-shaped / Oblong
- Strength: 10 mg Hydrocodone Bitartrate / 325 mg Acetaminophen
Mechanism of Action
The T 259 pill achieves its therapeutic effect through two distinct, synergistic mechanisms that target the central nervous system (CNS) to interrupt pain signaling.
- Hydrocodone Bitartrate (Opioid Agonist): Hydrocodone targets and binds to the opioid receptors (mu-opioid receptors) located throughout the brain and spinal cord. By activating these receptors, it inhibits the release of nociceptive (pain-sensing) neurotransmitters and alters the brain’s emotional perception of pain. It also induces a mild sense of euphoria by triggering dopamine release in the brain’s reward center.
- Acetaminophen (Non-Opioid Analgesic/Antipyretic): While its exact mechanism is not entirely localized, acetaminophen primarily works by inhibiting cyclooxygenase (COX) enzymes in the central nervous system. This blocks the synthesis of prostaglandins, which are chemicals responsible for amplifying pain signals and inducing fever.
Combining these two agents allows for multi-pathway pain relief, often requiring a lower dose of the opioid component than if it were used alone.
Dosage and Administration
Dosage must be heavily individualized based on the patient’s pain severity, prior opioid exposure, and individual metabolic risk factors.
- Standard Adult Dose: Typically 1 tablet every 4 to 6 hours as needed for severe pain.
- Maximum Daily Ceiling: The maximum dose is strictly limited by its acetaminophen component to protect liver health. Patients must not exceed 6 tablets per 24 hours (which equates to 60 mg of hydrocodone and 1,950 mg of acetaminophen).
- Administration: It can be taken with or without food. Taking it with food or a glass of milk may minimize the nausea frequently associated with initiating opioid therapy.
Side Effects
Side effects are categorized by frequency and severity. Opioids slow down structural body functions, while acetaminophen is generally well-tolerated at normal doses but toxic in excess.
Common Side Effects (Milder)
- Gastrointestinal: Constipation (highly common, as opioids slow bowel motility), nausea, vomiting, and dry mouth.
- Neurological: Drowsiness, dizziness, lightheadedness, and mental clouding.
- Dermatological: Pruritus (itching) due to opioid-induced histamine release.
Serious Side Effects (Require Immediate Medical Intervention)
- Severe low blood pressure (hypotension) or fainting.
- Adrenal insufficiency (symptoms include chronic fatigue, muscle weakness, loss of appetite).
- Urinary retention (difficulty urinating).
- Severe allergic reactions (anaphylaxis, hives, swelling of the face or throat).
Precautions
Before taking the T 259 pill, individuals must review their complete health history with a provider due to the systemic impacts of its active ingredients.
- Respiratory Status: Caution is required for patients with chronic obstructive pulmonary disease (COPD), severe asthma, or sleep apnea, as opioids suppress the brain’s respiratory drive.
- Liver and Kidney Health: Because acetaminophen is metabolized extensively by the liver and hydrocodone is cleared via the kidneys, compromised organ function can rapidly lead to toxic accumulation.
- Gastrointestinal and Intestinal Obstruction: Avoid use if you have known or suspected gastrointestinal obstructions, such as a paralytic ileus.
- Pregnancy and Lactation: Prolonged use during pregnancy can cause Neonatal Opioid Withdrawal Syndrome (NOWS), a life-threatening condition where the newborn experiences acute opioid withdrawal.
Boxed Warnings
The FDA attaches its strictest warning label a Boxed Warning to Hydrocodone/Acetaminophen combinations due to severe, systemic risks:
FDA Black Box Warnings
- Addiction, Abuse, and Misuse: Use of this medication exposes patients to the risks of opioid addiction, which can lead to overdose and death, even when taken exactly as prescribed.
- Life-Threatening Respiratory Depression: Serious, fatal respiratory depression (where breathing slows down or stops entirely) can occur. Monitoring is critical during initial dosing and after any dose increase.
- Hepatotoxicity (Liver Damage): Acetaminophen has been linked to acute liver failure, sometimes resulting in liver transplants or death. This typically occurs when doses exceed 4,000 mg per day or when multiple acetaminophen-containing products are taken simultaneously.
- Concomitant Use with Benzodiazepines: Taking opioids alongside benzodiazepines (e.g., Xanax, Valium), other CNS depressants, or alcohol may cause profound sedation, respiratory depression, coma, and death.
- Cytochrome P450 3A4 Interactions: Concomitant use with CYP3A4 inhibitors (like certain antibiotics or antifungals) can lead to a dangerous spike in hydrocodone levels in the blood, increasing the risk of fatal overdose.